Status:
COMPLETED
A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus
Lead Sponsor:
Hanoi Medical University
Collaborating Sponsors:
Karolinska Institutet
Swedish International Development Cooperation Agency (SIDA)
Conditions:
Snake Bite
Eligibility:
All Genders
Phase:
PHASE1
PHASE2
Brief Summary
In northern Vietnam, a vast majority of the most severe envenomed patients are bitten by Bungarus multicinctus. Hitherto, these victims have received supportive care only. The aims of this study were ...
Detailed Description
Venomous snakebites constitute a serious health problem in many Asian countries. In Vietnam, the burden of snakebite on the public health stimulated Calmette to conduct original studies at the Vaccine...
Eligibility Criteria
Inclusion
- Envenomed by B. multicinctus
- Showed clinical signs of systemic envenomation (neuromuscular signs)
- Provided written informed consent (during the year 2006)
Exclusion
- Pregnancy
- Patients had a known history of intolerance to equine serum
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00811239
Start Date
March 1 2004
End Date
December 1 2006
Last Update
December 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vietnam Poison Control Center, Bach Mai Hospital, HMU
Hanoi, Vietnam